Year 2021 / Volume 113 / Number 6
Original
Management of small intestinal bacterial overgrowth by pediatric gastroenterologists in Spain

436-441

DOI: 10.17235/reed.2020.7582/2020

Rafael Martín-Masot, Manuel Molina Arias, Juan José Díaz Martín, María Luz Cilleruelo Pascual, Carolina Gutiérrez Junquera, Ester Donat, Enriqueta Román Riechmann, Víctor M. Navas-López,

Abstract
Background: small intestinal bacterial overgrowth (SIBO) is a heterogeneous condition with nonspecific symptoms. This study aimed to report its management by pediatric gastroenterologists in Spain. Methods: a descriptive study was performed by means of a survey sent to 184 active members of the Spanish Society of Pediatric Gastroenterology, Hepatology and Nutrition (SEGHNP). Results: one hundred and forty-eight responses (80.4 %) were received. Forty-four patients had no predisposing condition, 31.1 % used antibiotics followed by probiotics, 33.1 % antibiotherapy concomitant with probiotics, 24.3 % only antibiotics and 10.8 % only probiotics. The diagnosis was established via clinical parameters in 73.8 % of participants and the therapeutic response was checked only by clinical data in 90 %. Conclusions: there is high variability in the management of SIBO among pediatric population in Spain.
Share Button
New comment
Comments
No comments for this article
References
1. Shimura S, Ishimura N, Mikami H, et al. Small intestinal bacterial overgrowth in patients with refractory functional gastrointestinal disorders. J. Neurogastroenterol. Motil. 2016;22:60–8. doi:10.5056/jnm15116.
2. Cares K, Al-Ansari N, MacHa S, et al. Short article: Risk of small intestinal bacterial overgrowth with chronic use of proton pump inhibitors in children. Eur. J. Gastroenterol. Hepatol. 2017;29:396–9.doi:10.1097/MEG.0000000000000815.
3. Siddiqui I, Ahmed S, Abid S. Update on diagnostic value of breath test in gastrointestinal and liver diseases. World J. Gastrointest. Pathophysiol. 2016;7:256. doi:10.4291/wjgp.v7.i3.256.
4. Sieczkowska A, Landowski P, Kaminska B, et al. Small Bowel Bacterial Overgrowth in Children. J. Pediatr. Gastroenterol. Nutr. 2016;62:196–207. doi:10.1097/MPG.0000000000000920.
5. Román E, Cilleruelo M. Síndrome de sobredesarrollo bacteriano. In: Ergon, editor. Tratamiento en Gastroenterología, Hepatología y Nutrición Pediátrica. 2016. page 343–53.
6. Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inform. 2009;42:377–81. doi:10.1016/j.jbi.2008.08.010.
7. Shimura S, Ishimura N, Mikami H, et al. Small Intestinal Bacterial Overgrowth in Patients with Refractory Functional Gastrointestinal Disorders. J. Neurogastroenterol. Motil. 2015;22:60–8. doi:10.5056/jnm15116.
8. Rezaie A, Buresi M, Lembo A, et al. Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus. Am. J. Gastroenterol. 2017;112:775–84. doi:10.1038/ajg.2017.46.
9. Tahan S, Melli LCFL, Mello CS, et al. Effectiveness of trimethoprim-sulfamethoxazole and metronidazole in the treatment of small intestinal bacterial overgrowth in children living in a slum. J. Pediatr. Gastroenterol. Nutr. 2013;57:316–8. doi:10.1097/MPG.0b013e3182952e93.
10. Scarpellini E, Giorgio V, Gabrielli M, et al. Rifaximin treatment for small intestinal bacterial overgrowth in children with irritable bowel syndrome: A preliminary study. Eur. Rev. Med. Pharmacol. Sci. 2013;17:1314–20. doi:10.1016/s0016-5085(11)63101-6.
11. Collins BS, Lin HC. Double-blind, placebo-controlled antibiotic treatment study of small intestinal bacterial overgrowth in children with chronic abdominal pain. J. Pediatr. Gastroenterol. Nutr. 2011;52:382–6. doi:10.1097/MPG.0b013e3181effa3b.
12. Shah SC, Day LW, Somsouk M, et al. Meta-analysis: Antibiotic therapy for small intestinal bacterial overgrowth. Aliment. Pharmacol. Ther. 2013;38:925–34. doi:10.1111/apt.12479.
13. Gatta L, Scarpignato C, McCallum RW, et al. Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth. Aliment. Pharmacol. Ther.2017;45:604–16. doi: 10.1111/apt.13928
14. Zhong C, Qu C, Wang B, et al. Probiotics for Preventing and Treating Small Intestinal Bacterial Overgrowth. J. Clin. Gastroenterol.2017;51:300–11. doi: 10.1097/MCG.0000000000000814.
15. Dionne J, Ford AC, Yuan Y, et al. A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in Treating Symptoms of Irritable Bowel Syndrome. Am. J. Gastroenterol.2018;113:1290–300. doi: 10.1038/s41395-018-0195-4.
Related articles

Editorial

Small intestinal bacterial overgrowth. A position paper of ASENEM-SEPD

DOI: 10.17235/reed.2023.10027/2023

Letter

Encephalopathy in short bowel syndrome: a diagnostic challenge

DOI: 10.17235/reed.2022.8826/2022

Letter

Pneumatosis intestinalis in a pediatric patient

DOI: 10.17235/reed.2021.8482/2021

Case Report

Metastatic Crohn’s disease in pediatrics

DOI: 10.17235/reed.2016.3948/2015

Original

Management of refractory esophageal stenosis in the pediatric age

DOI: 10.17235/reed.2016.3671/2015

Citation tools
Martín-Masot R, Molina Arias M, Díaz Martín J, Cilleruelo Pascual M, Gutiérrez Junquera C, Donat E, et all. Management of small intestinal bacterial overgrowth by pediatric gastroenterologists in Spain. 7582/2020


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 741 visits.
This article has been downloaded 420 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 10/10/2020

Accepted: 31/10/2020

Online First: 29/12/2020

Published: 04/06/2021

Article revision time: 11 days

Article Online First time: 80 days

Article editing time: 237 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology